{
    "eid": "2-s2.0-85103772946",
    "title": "No increased acute kidney injury rate through giving an intravenous colistin loading dose in pediatric patients",
    "cover-date": "2021-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acute kidney injury",
        "Colistin",
        "Loading dose",
        "Nephrotoxicity",
        "Pediatric"
    ],
    "authors": [
        "Noppadol Wacharachaisurapol",
        "Surinda Kawichai",
        "Ankanee Chanakul",
        "Thanyawee Puthanakit"
    ],
    "citedby-count": 1,
    "ref-count": 35,
    "ref-list": [
        "The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2014concepts appraised by the example of antimicrobial agents",
        "Colistin and polymyxin B susceptibility testing for carbapenem-resistant and MCR-positive Enterobacteriaceae: comparison of Sensititre, MicroScan, Vitek 2, and Etest with broth microdilution",
        "Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world",
        "Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis",
        "Systemic colistin use in children without cystic fibrosis: a systematic review of the literature",
        "Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium",
        "Augmented renal clearance, low \u03b2-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study",
        "Safety and efficacy of intravenous colistin use for the treatment of nosocomial multidrug-resistant Acinetobacter baumannii infections in a pediatric intensive care unit",
        "Epidemiology of acute kidney injury in critically ill children and young adults",
        "Intravenous colistin for multidrug-resistant Gram-negative infections in critically ill pediatric patients",
        "Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis",
        "The use of colistin in critically ill children in a pediatric intensive care unit",
        "Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital",
        "KDIGO clinical practice guidelines for acute kidney injury",
        "Antimicrobial susceptibility testing of colistin \u2014 evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp",
        "Attributable risk and time course of colistin-associated acute kidney injury",
        "Pharmacokinetics of colistin following a single dose of intravenous colistimethate sodium in critically ill neonates",
        "Dosing guidance for intravenous colistin in critically-ill patients",
        "Percentage of susceptible organisms isolated from all specimen, 85 hospitals, Jan\u2013Dec 2018",
        "High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia",
        "Population pharmacokinetics of intravenous colistin in pediatric patients: implications for the selection of dosage regimens",
        "Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?",
        "Old agent, new experience: colistin use in the paediatric intensive care unit \u2014 a multicentre study",
        "Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria",
        "Risk factors for colistin-associated nephrotoxicity",
        "The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: results from two reference hospitals and review of literature",
        "New equations to estimate GFR in children with CKD",
        "AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions",
        "The use of intravenous colistin among children in the United States: results from a multicenter, case series",
        "International Consensus Guidelines for the Optimal Use of the Polymyxins: endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)",
        "Coly-Mycin\u00ae M Parenteral (Colistimethate for Injection, USP)",
        "Augmented renal clearance in critically ill pediatric patients: does it impact the outcome of pharmacotherapy?",
        "Augmented renal clearance: a common condition in critically ill children",
        "Colistin loading dose: evaluation of the published pharmacokinetic and clinical data",
        "Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}